We examined the fecal fat excretion of mildly hypertriacylglycerolemic subjects who ingested soft cookies containing 1(3)-behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) for 7 days. The subjects included 14 healthy men (average age; 44.9 ± 1.7) whose fasting plasma triacylglycerol level ranged from 150 to 250 mg/ dL. Every day for 7 days, the subjects ate 5 soft cookies containing margarine with the BOO-rich experimental oil (BOO intake, 2.46 g/day). The placebo group ate soft cookies containing margarine without BOO. This study was a randomized double-blind, placebo-controlled, crossover study. Feces were collected for 3 days prior to the end of the treatment period, and fecal fat and fatty acid composition were determined. The fecal wet weight was significantly increased in BOO group compared with that in the placebo group. Moreover, fecal fat and fatty acid level were significantly higher in the BOO group than in the placebo group. There were no significant differences in the fecal fatty acid composition of the BOO and placebo groups. These results suggest that dietary BOO increases fecal excretion of dietary fat in humans. However, BOO does not increase the excretion of specific fatty acids; it increases the excretion of all fatty acids of dietary origin, which may lead to lower and delay intestinal absorption of dietary fat.
INTRODUCTION
We previously reported that dietary 1 3 -behenoyl-2,3 1 -dioleoyl-rac-glycerol BOO prevented the deposition of visceral fat in rats 1 . Studies using structured triacylglycerols containing behenic and medium-chain fatty acids reported the suppression of dietary fat absorption 2 4 , which was ascribed to the reduced absorption of behenic acid. However, in our previous study, fecal excretion of both behenic acid and fatty acids other than behenic acid was increased by BOO consumption 1 . In a study using lymphcannulated rats, the lymphatic recovery of behenic and oleic acids was reduced after BOO was administered to the stomach 1 . We also showed that the lymphatic recovery of radiolabeled oleic acid originating from trioleoylglycerol OOO was significantly reduced when BOO was mixed with OOO. In an in vitro study, Arishima et al. reported that BOO suppressed the hydrolysis of OOO as well as itself by pancreatic lipase 5 . Therefore, we suggested that BOO decreased fat absorption by suppressing the hydrolysis of BOO itself and by inhibiting the hydrolysis of triacylglycerols other than BOO. There is a possibility that the prevention of absorption of behenic acid and other fatty acids by BOO is a major cause of the decreased visceral fat deposition in rats.
Although studies using experimental animals have reported the inhibitory effects of BOO on fecal excretion of dietary fat, to our knowledge, the effects of BOO in humans has not been reported thus far. In this study, we examined the effects of BOO on the fecal excretion of dietary fats in subjects with postprandial hypertriacylglycerolemia.
EXPERIMENTAL
The present study was initiated upon ethical approval by the committee of TES Holdings Co., Ltd. Tokyo, Japan . In compliance with the principles of the Declaration of Helsinki, written consent was obtained from all volunteers after the study protocol, purpose and methodology of the study, and rights of the subjects were explained to them in advance.
Subjects
From among a mildly hypertriacylglycerolemic subjects with fasting plasma triacylglycerol levels of 150-250 mg/dL, we selected 14 subjects who defecated once or more times a day, who were not administered medicines and were not going to the hospital regularly, and who were not doing severe physical work. The subjects were aged 30-60 years.
Sample collection
Soft cookies baked using margarine containing BOO-rich experimental oil were used as the test cookies, and soft cookies made with margarine that did not contain the BOO-rich experimental oil were used as the placebo cookies. The BOO-rich experimental oil was prepared according to the method described by Kojima et al. 1 . Margarine oil content, 80.8 contained soybean, rapeseed, palm, and palm kernel oils. In the test margarine, 32.3 of the vegetable oil was replaced with the BOO-rich experimental oil. The fatty acid compositions of the test margarines are shown in Table 1 . The BOO content in the BOOrich experimental oil was 55 . The composition of soft cookies was as follows per 100 g : 24.3 g margarine; 19.4 g white soft sugar; 0.05 g vanilla flavor; 7.8 g whole egg, and 48.5 g cake flour. Soft cookies was 11.4 g a piece including 0.492 g of BOO. The BOO intake was 2.46 g/day.
Study design
We conducted a double-blind, placebo-controlled, crossover study. There was an adjustment period of 4 days before the start of the treatment periods. The subjects were randomly divided into one of the 2 groups and were given 2 soft cookies at breakfast and 3 soft cookies at dinner for 7 days. The dietary fat, during the treatment period, was adjusted to 60 g/day. All subjects were given the same meal except for the type of soft cookies for the adjustment period and the 7-day treatment periods. After an 8-day washout period, the subjects were crossed over and the second adjustment and 7-day treatment periods were started. All the participants were instructed to avoid irregular lifestyles and excessive alcohol, and to maintain their regular physical activity throughout the entire study periods. In addition, the subjects were instructed to keep records on the meal intakes and their health condition, such as information regarding diarrhea, constipation, headache, agrypnia, buzzing, and dizziness.
Analysis of blood
At the end of the treatment period, blood samples were collected from each subject. Plasma was prepared from heparinized blood by centrifugation at 3,000 rpm for 10 min at 5 . Levels of plasma triacylglycerol, total cholesterol, high density lipoprotein HDL -cholesterol, glutamicoxaloacetic transaminase GOT , and glutamate pyruvate transaminase GPT were analyzed using the JCA-BM8060 automated system JEOL, Japan . Glucose levels were analyzed using the JCA-BM9130 automated system JEOL, Japan .
Analysis of feces
Feces were collected during the final 3 days of each treatment period. After weighing, feces were freeze-dried and reweighed. Fecal moisture was calculated from the weights before and after lyophilization by using the Kett moisture measuring system Kett Electric Laboratory, Japan . After the addition of hydrochloric acid to the dried feces, total fat was extracted in a solution of chloroform : methanol 2:1 6 . Fecal fat was saponified with 0.5 mol/L sodium hydroxide-methanol solution and methylated using a boron trifluoride-methanol complex, as described by Kojima et al. 1 . Fatty acid methyl esters were subjected to capillary gas-liquid chromatography using a SHIMADZU GC-2014 apparatus equipped with ULBON HR-SS-10 GL Sciences, Japan . After the feces were incinerated, minerals were extracted with hydrochloric acid and filtered. Calcium, magnesium, sodium, and potassium levels were determined by atomic absorption spectrophotometry 6 . Levels of vitamins A, D, E, and K were measured based on the method of Standard Tables of Food Composition in Japan 6 . 
Statistical analysis
All data are expressed as means SE. Statistical analyses of data were performed using the paired t-test. Differences were considered significant at p < 0.05 SPSS Inc., Japan .
RESULTS

Subject characteristics
The details of the participants backgrounds are shown in Table 2 . The initial at screening mean plasma triacylglycerol level of the subjects was 197 9 mg/dL.
Adverse effects
Adverse effects such as diarrhea, constipation, headache, agrypnia, buzzing, and dizziness were not observed in either the BOO or the placebo groups during the treatment period.
Blood biochemical parameters
The plasma biochemical parameters of the subjects are shown in Table 3 . There were no differences between the plasma biochemical indexes of the BOO and placebo groups.
3.4 Lipid excretion in feces and fecal fatty acid composition Fecal wet weight and moisture content were significantly higher in the BOO group than in the placebo group Table  4 . Similarly, excretion of fecal fat and total fatty acid levels were higher in the BOO group than in the placebo group Table 4 . The fatty acid composition of fecal fat in the placebo and BOO groups were similar Fig. 1 .
Excretion of fecal minerals and vitamins
The minerals and fat-soluble vitamins that were excreted in the feces are shown in Table 5 . There were no differenc- es in the levels of these minerals and fat-soluble vitamins between the 2 groups.
DISCUSSION
The present study showed that dietary BOO increased the excretion of fats and fatty acids in the feces Table 4 . The fatty acid compositions of fecal fat in the placebo and BOO groups were similar Fig. 1 , which suggest that BOO increased the excretion of all the dietary fatty acids. In a previous study on rats, we showed that dietary BOO increased the fecal excretion of dietary fat and that the lymphatic recovery of radiolabeled OOO was suppressed by the addition of BOO 1 . Arishima et al. also showed that BOO inhibited the hydrolysis of triacylglycerol by pancreatic lipase in vitro 5 . These findings suggest that BOO reduces fat absorption through the inhibition of hydrolysis of triacylglycerol in the intestinal lumen. In our previous study on rats, 20 of the dietary fat was replaced with BOO-rich experimental oil, and the BOO content in dietary fat was 8.4 1 . In the present study, the BOO intake was 2.46 g/day, and the total dietary fat intake was 60 g/day; therefore, BOO accounted for only 4.1 of the total dietary fat. These results suggest that BOO, in a relatively small amount, can significantly suppress dietary fat absorption in humans.
Micellar solubilization of hydrolysis products of triacylglycerols is one of the important processes of fatty acid absorption in the intestine 7, 8 . In addition to the inhibition of pancreatic lipase activity by BOO, our results in which BOO increased the excretion of all the dietary fatty acids also suggest that BOO and its hydrolysis products might suppress micellar solubility of hydrolysis products of triacylglycerols, such as free fatty acids and monoacylglycerols, other than BOO. However, there is no substantial evidence of the inhibitory effect of BOO on the micellar solubility of hydrolysis products. Further studies are required on this point.
In the rats fed a diet containing 28 fat including 2.3 BOO, fecal excretion of both behenic acid and other fatty acids was increased 1 . In rats with a cannulated thoracic lymph duct, the lymphatic recovery of behenic acid was significantly lower than that of oleic acid that is derived from OOO and BOO mixture 10 BOO 1 . These results showed that intestinal absorption of behenic acid was lower than that of the unsaturated fatty acids under these experimental conditions. Behenic acid may have low absorption compared to unsaturated fatty acids because of its higher melting point and the lower hydrolysis rate of triacylglycerols containing behenic acid by pancreatic lipase 5 . However, in the present study, the amount of behenic acid excreted in the feces was not increased in the BOO group Fig. 1 . Intestinal absorption of stearic acid has been reported to be significantly lower than that of unsaturated fatty acids 9 . However, Ikeda et al. showed that stearic acid absorption was accelerated when triacylglycerols rich in stearic acid were mixed with fats rich in unsaturated fatty acids 10 . In fact, the rate of absorption of stearic acid was positively correlated with the amount of unsaturated fats consumed 10 . Although data on behenic acid absorption is not available, there is a strong possibility that behenic acid absorption may be accelerated when the diet is high in unsaturated fats. In the present study, behenic acid intake was only 0.76 g per 60 g of dietary fat and the behenic acid content in dietary fat was relatively lower than that in the rat study 1 . Therefore, there is a possibility that the absorption rate of behenic acid was not so low in our experimental condition and the increase of fecal excretion of behenic acid was negligible.
Although the excretion of total fat and fatty acids in the feces was significantly increased by BOO consumption, the increments in the fecal total fat and fatty acids outputs were 0.93 g/3 days and 0.61 g/3 days, respectively. These are relatively small amounts. A previous study that used oolong tea polymerized polyphenols OTPP , which is approved as food for specified health uses FOSHU in Japan, reported an increase of approximately 3.3 g/day of fecal total fat when the intake of OTPP was 207.5 mg/day 11 . When mannooligosaccharides, which are also approved as FOSHU, were taken for 3 g/day, an increase of approximately 0.7-0.8 g/day of fecal fat was observed 12, 13 . Therefore, to obtain an effective level of fecal fat excretion, it is necessary to increase the dosage of BOO.
In the present study, BOO intake did not influence the absorption of minerals and fat-soluble vitamins Table 5 . Further, no adverse health effects were observed in subjects who consumed dietary BOO. Thus, BOO can be used as a safe food material.
We have shown that BOO can be utilized as a possible functional food that prevents the intestinal absorption of fat. In a study on rats, we determined that BOO had antiobesity activity. Therefore, BOO may be used as a func- Dietary BOO increases fecal fat excretion in humans tional food for preventing obesity. Hence, further studies are necessary to determine the appropriate dose of BOO.
CONCLUSION
The present study demonstrated that BOO increased the fecal excretion of all fatty acids of dietary origin in humans. The results suggest that BOO suppresses intestinal absorption of dietary fats.
